Notice & Comment

Notice & Comment

Notice & Comment

Don’t Panic About House v. Burwell, by Nicholas Bagley

Don’t panic about House v. Burwell. From the New York Times on what might happen if the House prevails in House v. Burwell: A study by the Department of Health and Human Services estimated that premiums for midlevel “silver plans” could rise by nearly 30 percent without [cost-sharing] reimbursements. Many consumers would be protected, since […]

Notice & Comment

D.C. Circuit Review – Reviewed: The Dissents that Matter Most to Chief Judge Garland, by Aaron Nielson

This week, Chief Judge Garland sent his questionnaire to the Senate. As I reviewed that “lengthy” submission, my mind turned again to “brooding spirts.” In particular, it is interesting that Garland’s list of his “most significant” opinions includes two dissents. To begin, here is Garland’s list: Cause of Action v. FTC (2015) Wagner v. FEC […]

Notice & Comment

A Government Defeat in House v. Burwell

Having previously held that the House of Representatives has standing to sue, the district court in House v. Burwell has now held that the Obama administration is violating the Appropriations Clause in making cost-sharing payments under the ACA in the absence of the requisite congressional appropriation. The court has stayed its decision pending appeal, meaning […]

Notice & Comment

Zika and Pregnancy-Specific Vaccines’ Regulatory Lacunae

In my next two posts, I will investigate the relationship between regulatory approval of vaccines and the response to the global public health emergency surrounding the spread of the Zika virus. That emergency has resurrected and brought into sharper relief some of the most vexing questions surrounding the regulatory state and pregnancy: the appropriate circumstances, […]

Notice & Comment

Eminent Domain for Drugs

From his perch at Politico, Dan Diamond has launched what promises to be a terrific new health-policy podcast, Pulse Check, with an interview with CMS’s acting administrator, Andy Slavitt. The interview is refreshingly candid: among other things, Slavitt confesses that the Obama administration has a lot of work to do to win back the hearts […]

Notice & Comment

More on Amtrak and “Company A,” by Daniel Hemel

In a characteristically thoughtful post discussing the D.C. Circuit’s decision in American Association of Railroads v. Department of Transportation, Aaron Nielson writes: Imagine three companies—let’s call them A, B, and C. Each manufactures cars. Imagine further that Congress authorizes A to regulate B and C, and A uses that power to benefit itself, for instance […]

Notice & Comment

ABA Section to Host Discussion on Federal Sector Personnel Law

The ABA Section of Administrative Law and Regulatory Practice, Government Personnel Committee will host two brown bag lunches this month on the latest developments at the Merit Systems Protection Board (“MSPB”) and Equal Employment Opportunity Commission (“EEOC”), Office of Federal Operations. These brown bags are part of a larger series of discussions the Government Personnel […]